https://www.selleckchem.com/pr....oducts/tinengotinib.
01). An oral Stenotrophomonas relative abundance of 36% predicted infection (sensitivity 96%, specificity 93%). No association of S. maltophilia infection with fecal relative abundance was found. Cumulative meropenem exposure was associated with increased infection risk (hazard ratio [HR] 1.17, 95% CI 1.01 - 1.35, p = 0.03). Conclusions Herein, we identify the oral microbiome as a potential source for S. maltophilia infection and highlight cumulative carbapenem use as a risk factor for S. maltophilia in leukemia patients. These dat
Aimer
Commentaire
Partagez
